STAT April 19, 2023
Sallie Permar and Karen Acker

The calamity of March 2020 arrived two years later for pediatric units. In the fall of 2022, a tidal wave of respiratory viral illnesses sent children to emergency rooms in droves when enterovirus, respiratory syncytial virus (RSV), and influenza peaked in close succession, bombarding young children who had remained mostly unexposed to these viruses during the most acute years of the Covid pandemic.

The result was scores of infants and toddlers in need of hospitalization, greatly exceeding the capacities of our nation’s hospitals. A significant burden was placed on an already beleaguered pediatric workforce of nurses, respiratory therapists, and clinicians, and sick children were left waiting in hallways or were transported across state lines for beds. Even after the RSV...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article